Hypernatremia: Difference between revisions

	Hypernatremia Microchapters
Home
Patient Information
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Hypernatremia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
CT
MRI
Other Diagnostic Studies
Other Imaging Findings
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Case Studies
Case #1
Hypernatremia On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hypernatremia All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypernatremia
CDC on Hypernatremia
Hypernatremia in the news
Blogs on Hypernatremia
Directions to Hospitals Treating Hypernatremia
Risk calculators and risk factors for Hypernatremia

Revision as of 20:21, 9 December 2011

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor(s)-In-Chief: Jack Khouri

The cornerstone of treatment is administration of free water to correct the relative water deficit. Water can be replaced orally or intravenously.

Overly rapid correction of hypernatremia is potentially very dangerous. As we mentioned before, The body (in particular the brain) adapts to the higher sodium concentration. Rapidly lowering the sodium concentration with free water, once this adaptation has occurred, causes water to flow into brain cells and causes them to swell (cerebral edema). This can lead to cerebral edema, potentially resulting in seizures, permanent brain damage, or death. Central pontine myelinolysis can also occur with over rapid correction of the sodium which should be about 0.5 meq/l/hour and no more than 1 meq per hour. Significant hypernatremia should be treated carefully by a physician or other medical professional with experience in treatment of electrolyte imbalances.

Central DI should be treated with desmopressin and drugs that increase vasopressin release eg Clofibrate.

Nephrogenic DI can be treated with Thiazide diuretics, low salt and low protein diet.

@@ Line 23: / Line 23: @@
 ==[[Hypernatremia history and symptoms|History and Symptoms]]==
-==Labs and Procedures==
+==[[Hypernatremia laboratory tests|Laboratory tests]]==
-* Urine osmolarity is essential to differentiate renal from extrarenal water loss. A normal kidney would respond to hypernatremia by excreting a highly concentrated urinewith a urine osmolality >800 mosmol/kg.
-** Urine osmolarity <300 mosm/kg is consistent with renal water losses due to diabetes insipidus (neurogenic vs nephrogenic).
-** Urine osmolarity between 300 and 800 mosm/kg indicates partial diabetes insipidus or osmotic diuresis.
-** Urine osmolarity >800 mosm/kg points out to insensible or GI losses, increased sodium ingestion or primary hypodypsia.
-* The water deprivation test
-** The objective of this test is to distinguish the origin of diabetes insipidus (DI).
-** Desmopressin (AVP), a synthetic analogue of vasopressin, is effective in patients with central DI.
-** Upon AVP adminstration, patients will have different urine osmolarities depending on their DI etiology.
-** Patients with central DI have intact kidney response to vasopressin and will have a substantial increase in urine osmolarity in response to water deprivation and desmopressin administrarion.
-** Patients with nephrogenic DI have little or no increase in urine osmolarity in response to AVP.
-** Patients with partial central DI show an increase in urine osmolarity of >10%.
 ==Treatment==